DENTSPLY SIRONA (NASDAQ:XRAY) Given Outperform Rating at Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “outperform” rating restated by analysts at Barrington Research in a research note issued to investors on Thursday, Benzinga reports. They currently have a $41.00 price target on the medical instruments supplier’s stock. Barrington Research’s price target would suggest a potential upside of 33.94% from the stock’s previous close.

XRAY has been the subject of several other research reports. SVB Leerink began coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 target price for the company. Leerink Partnrs reiterated an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, January 19th. Piper Sandler lifted their price objective on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a research report on Friday, January 12th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $42.00 price objective on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and a consensus target price of $39.50.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY traded up $0.25 during trading on Thursday, hitting $30.61. 78,096 shares of the stock were exchanged, compared to its average volume of 3,400,326. DENTSPLY SIRONA has a 1-year low of $26.27 and a 1-year high of $43.24. The company has a market capitalization of $6.35 billion, a price-to-earnings ratio of -49.34, a price-to-earnings-growth ratio of 1.25 and a beta of 0.98. The company’s fifty day simple moving average is $32.89 and its 200-day simple moving average is $32.88. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.95 and a current ratio of 1.38.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, topping the consensus estimate of $0.43 by $0.01. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $972.61 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. DENTSPLY SIRONA’s revenue was up 3.0% on a year-over-year basis. During the same quarter last year, the company earned $0.46 EPS. Sell-side analysts expect that DENTSPLY SIRONA will post 2.05 EPS for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently made changes to their positions in the company. Principal Securities Inc. bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth $26,000. VisionPoint Advisory Group LLC raised its position in shares of DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 395 shares during the last quarter. Headlands Technologies LLC acquired a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth $30,000. Parkside Financial Bank & Trust grew its stake in shares of DENTSPLY SIRONA by 163.7% during the first quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock worth $46,000 after purchasing an additional 568 shares during the period. Finally, Point72 Asset Management L.P. acquired a new stake in shares of DENTSPLY SIRONA during the second quarter worth $44,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.